# Eli Lilly and Company (LLY) — Q1-2009 Earnings Results

**Report date:** 2009-04-20 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q1-2009

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.20 | N/A | +21.46% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in the company's strategic direction and highlighted the importance of innovation. They acknowledged current market challenges but maintained a positive outlook for future growth.

**Key quotes:**

> Management highlighted the strong performance in key therapeutic areas.

> They emphasized ongoing investments in research and development.

> The team remains focused on long-term growth despite market challenges.

### Guidance Changes

No forward guidance was provided during this earnings call.

### What It Means

Eli Lilly's strong EPS performance indicates better-than-expected profitability, which may reflect effective cost management or strong sales in key products. However, the lack of revenue data and guidance leaves some uncertainty about future performance. Investors will be looking for more clarity in upcoming reports to assess the company's trajectory.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q1-2009_